PT Graha Layar Prima Tbk (BLTZ.JK)
IDR 2000.0
(0.0%)
IDR 2000.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1061.47 Billion | 1058.36 Billion | 284.9 Billion | 255.83 Billion | 1414.59 Billion | 1184.32 Billion |
| Cost of Revenue | 615.73 Billion | 647 Billion | 281.11 Billion | 323.19 Billion | 872.73 Billion | 662.43 Billion |
| Gross Profit | 445.74 Billion | 411.36 Billion | 3.79 Billion | -67.35 Billion | 541.85 Billion | 521.89 Billion |
| Operating Expenses | 333.57 Billion | 310.79 Billion | 205.75 Billion | 220.47 Billion | 395.54 Billion | 435.4 Billion |
| Selling, General and Administrative Expenses | 333.57 Billion | 310.79 Billion | 205.75 Billion | 220.47 Billion | 395.54 Billion | 435.4 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 5.82 Billion | -9.85 Billion | -106.03 Billion | 7.23 Billion | 4.05 Billion |
| Cost and Expenses | 949.31 Billion | 957.79 Billion | 486.86 Billion | 543.66 Billion | 1268.28 Billion | 1097.83 Billion |
| Operating Income | 112.16 Billion | 75.13 Billion | -230.61 Billion | -413.7 Billion | 131.46 Billion | 86.49 Billion |
| Interest Expense | 128.05 Billion | 132.08 Billion | 125.02 Billion | 119.31 Billion | 16.74 Billion | 10.23 Billion |
| Income Tax Expense | 4.05 Billion | 1.92 Billion | -90.52 Billion | -87.18 Billion | 31.36 Billion | 16.04 Billion |
| Earnings before Tax | -9.58 Billion | -56.94 Billion | -355.63 Billion | -533.01 Billion | 114.71 Billion | 51.27 Billion |
| Net Income | -13.65 Billion | -58.86 Billion | -265.11 Billion | -445.82 Billion | 83.34 Billion | 35.22 Billion |
| Earnings Per Share Basic | -15.62 | -67.36 | -303.35 | -510.14 | 95.36 | 40.31 |
| Earnings Per Share Diluted | -15.62 | -67.36 | -303.35 | -510.14 | 95.36 | 40.31 |
| Weighted Average Shares Outstanding | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million |
| Gross Margin | 0.42 | 0.39 | 0.01 | -0.26 | 0.38 | 0.44 |
| EBIT Margin | 0.27 | 0.07 | -0.81 | -1.62 | 0.09 | 0.10 |
| Profit Margin | -0.01 | -0.06 | -0.93 | -1.74 | 0.06 | 0.03 |
| EBITDA | 287.23 Billion | 257.74 Billion | -21.78 Billion | -163.74 Billion | 333.14 Billion | 262.92 Billion |
| Earnings Before Tax Margin | 0.11 | 0.07 | -0.81 | -1.62 | 0.09 | 0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 276.37 Billion | 352.5 Billion | 265.1 Billion | 1061.47 Billion | 264.69 Billion | 260.99 Billion |
| Cost of Revenue | 157.92 Billion | 194.9 Billion | 156.47 Billion | 616.65 Billion | 136.45 Billion | 156.64 Billion |
| Gross Profit | 118.44 Billion | 157.6 Billion | 108.62 Billion | 444.82 Billion | 128.24 Billion | 104.35 Billion |
| Operating Expenses | 90.45 Billion | 92.76 Billion | 83.73 Billion | 323.86 Billion | 85.71 Billion | 84.42 Billion |
| Selling, General and Administrative Expenses | 90.45 Billion | 91.16 Billion | 85.03 Billion | - | 81.28 Billion | -18.25 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -1.38 Billion | -1.6 Billion | 1.84 Billion | -10.46 Billion | -4.42 Billion | -12.19 Billion |
| Cost and Expenses | 248.38 Billion | 287.66 Billion | 240.21 Billion | 940.51 Billion | 222.16 Billion | 241.06 Billion |
| Operating Income | 27.98 Billion | 64.83 Billion | 23.58 Billion | 120.96 Billion | 42.53 Billion | -2.07 Billion |
| Interest Expense | 35.43 Billion | 29.3 Billion | 31.69 Billion | 128.05 Billion | 30.21 Billion | 32.91 Billion |
| Income Tax Expense | 4.6 Billion | 9.7 Billion | 2.03 Billion | 4.05 Billion | -254.8 Million | -3.58 Billion |
| Earnings before Tax | 6.24 Billion | 28.42 Billion | -6.8 Billion | -9.58 Billion | 23.59 Billion | -34.99 Billion |
| Net Income | 1.63 Billion | 18.71 Billion | -8.84 Billion | -13.65 Billion | 23.84 Billion | -31.41 Billion |
| Earnings Per Share Basic | 1.87 | 21.42 | -10.12 | - | 27.29 | -35.94 |
| Earnings Per Share Diluted | 1.87 | 21.42 | -10.12 | - | 27.29 | -35.94 |
| Weighted Average Shares Outstanding | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million | 873.93 Million |
| Gross Margin | 0.43 | 0.45 | 0.41 | 0.42 | 0.48 | 0.40 |
| EBIT Margin | 0.15 | 0.30 | 0.20 | - | 0.31 | -0.01 |
| Profit Margin | 0.01 | 0.05 | -0.03 | -0.01 | 0.09 | -0.12 |
| EBITDA | 41.67 Billion | 104.95 Billion | 52.59 Billion | - | 83.31 Billion | -2.07 Billion |
| Earnings Before Tax Margin | 0.10 | 0.18 | 0.09 | 0.11 | 0.16 | -0.01 |
CAZ
ABCA
300707
CG
NXLLF
PHRMASI